Concepedia

Anke Bill

AB

15

Publications

1.1K

Citations

13

H-Index

2006

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of Bonn

Novartis (United States)

Novartis (United Kingdom)

Anke Bill is an author at Novartis (Switzerland) specializing in medicine, molecular biology, and pharmacology.

ORCID

Top concepts

Publications per year

2006–2019

15

Publications

15

Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling

Adrian Britschgi, Anke Bill, Heike Brinkhaus et al. · Proceedings of the National Academy of Sciences · 2013 · 319 citations · Full text

To “Grow” or “Go”: TMEM16A Expression as a Switch between Tumor Growth and Metastasis in SCCHN

Daniel J. Shiwarski, Chunbo Shao, Anke Bill et al. · Clinical Cancer Research · 2014 · 114 citations · Full text

ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer

Anke Bill, Abraham Gutierrez, Sucheta Kulkarni et al. · Oncotarget · 2015 · 110 citations · Full text

Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation

Patricia Fernández‐Nogueira, Mario Mancino, Gemma Fuster et al. · Clinical Cancer Research · 2019 · 104 citations

Small Molecule-facilitated Degradation of ANO1 Protein

Anke Bill, Michelle Lynn Hall, Jason Borawski et al. · Journal of Biological Chemistry · 2014 · 83 citations · Full text

, , +5

Rows per page

1–5 of 15